Part 3 of 3.

My guest for this week’s episode is Alok Tayi, Founder of Vibe Bio, a life science company that funds and guides high-potential drug programs through value inflection points. Vibe Bio’s core comprises a community of scientists, patients, and partners dedicated to helping biotechs find the promising treatments that patients deserve.

Prior to founding Vibe Bio, Alok started and ran several life science-focused software companies, including PreScouter, TetraScience, and the Life Sciences division at Egnyte. Join us as we sit down with Alok to talk about the origins of the Biotech2050 podcast, how serendipity has played a role in his career, and how he does his best to create those opportunities for others.

Alok also discusses how medical conditions in his family led to Vibe Bio’s creation, and how Vibe’s goal is to pinpoint diseases with unmet needs, leveraging AI to find medicines with the highest chances of providing cures. Lastly, learn how Vibe Bio can offer newly spun-out biotechs benefits at every inflection point. Please enjoy my conversation with Alok Tayi.

Find Our Guest, Alok Tayi, at these links:
https://www.linkedin.com/in/aloktayi/
https://www.vibebio.com
https://www.biotech2050.com/

Find Our Host, Jon Chee, at these links:
https://www.linkedin.com/in/jonchee
https://www.excedr.com

Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Podcast Website: https://www.thebiotechstartupspodcast.com/

Timestamps:
00:00 Intro
01:44 Episode start, starting the Biotech2050 Podcast, biotech innovation and facilitating those conversations
05:20 Fostering connections, serendipity’s effect on Alok’s journey and creating those opportunities for others
08:26 Diseases in the family and how they sparked Vibe Bio’s mission, the challenge of funding cures rather than finding them
10:47 Developing medicine from outside the industry, democratizing the drug development domain
12:54 Exponential scaling in expenses leads to medicines gravitating toward economic potential, recency bias
14:34 “Activation energy”, pinpointing unmet needs in industry and leveraging AI to find highest potential cures
17:26 Key inflection points to know, what Vibe Bio brings to those inflection points
20:58 Vibe Bio’s plans during the next couple of years
22:37 Alok’s shout outs, giving advice to a younger self, growth is non-linear, think long term
25:18 Outro

Enriched Notes:
Topics Mentioned:
Biotech2050 Podcast https://www.biotech2050.com/
Clora https://www.clora.com/
JPM Conference https://www.jpmorgan.com/about-us/events-conferences/health-care-conference
Biotech Podcasts to Listen To https://www.excedr.com/blog/biotech-podcasts-to-listen-to
Vibe Bio https://www.vibebio.com/
What Is Capital Outlay https://www.excedr.com/blog/what-is-capital-outlay
Venture Capital https://www.excedr.com/category/venture-capital
Angel Investors https://www.excedr.com/resources/angel-funding-and-angel-investors
Seed Round https://www.excedr.com/resources/seed-round-funding-explained
Series A, B, & C Funding https://www.excedr.com/resources/series-funding-explained
Activation energy https://www.britannica.com/science/activation-energy
Slush Fund https://en.wikipedia.org/wiki/Slush_fund
Tech Transfer https://www.excedr.com/blog/what-is-tech-transfer
Spinning Out of Academia https://www.excedr.com/resources/how-to-spin-out-of-academia-and-into-a-startup

People Mentioned:
Rahul Chaturvedi https://www.linkedin.com/in/rahulchaturvedi/
Sam Stupp https://stupp.northwestern.edu/cv/
George Whitesides https://www.linkedin.com/in/george-whitesides-7ba1189/
John Kelty https://www.linkedin.com/in/john-kelty-96926885